18.6 C
Buenos Aires
domingo 29 noviembre 2020 07:25
Inicio English versions

English versions

Change at the top for Sanofi Argentina?

Remote working has become a definitive part of the corporate environment. French drugmaker Sanofi seems to hold that it's as effective to run Argentine operations from Europe as from Buenos Aires, with its Southern Cone general manager to set up a virtual offfice Switzerland. The ongoing novel coronavirus pandemic has...

Sigman to make Covid-19 vaccine in Argentina

A month ago Argentina's president received the local head of Pfizer to announce that the drugmaker would begin clinical trials in Argentina. The annocement generated the public idea that a vaccine was around the corner. Now expectations are even higher as it's announced that AstraZeneca intends to manufacture...

Catalent to build third Argentine plant

The Softgel specialist Catalent is expanding its capacity in Argentina. Led locally by Hernán Mellone, the company, which dominates the local softgel market, will invest an estimated US$ 5 million in a new plant. US softgel specialist Catalent hasn't been put off by the ongoing lockdown, nor the local...

Megalabs brings cannabidiol to Latam

Regulations on the use of treatments based on cannabidiol vary across the region. In Argentina, the use of medicinal oil must be requsted under "compassionate use". But a major Latin American player has become the representative of a US firm specialising in medicinal cannabis. The major Latin American multinational...

Baxter winds up Argentina operation

The US drugmaker Baxter has closed the doors on its Argentina operation to definitively leave the country. It leaves Argentina's Comarsa as its local representative. Another pharmaceutical multinational has bowed out from Argentina. Pharmabiz has learned that the US giant Baxter is closing its renal care business – its last remaining...

Pierre Fabre exits Argentina

Several major multinational companies have taken the decision to pull out of Argentina during the Covid-19 lockdown. The airline Latam and the sports brand Nike are now followed by the French drugmaker Pierre Fabre. Company restructuring and the local devaluation are the main factors responsible. Pierre Fabre's opening of a new...

Pfizer hypes Argentina vaccine trial

Pfizer's local general manager Nicolás Vaquer visited the presidential residence in Olivos on what was a holiday weekend in Argentina to tell President Alberto Fernández that Pfizer will carry out trials of its Covid-19 vaccine candidates in the country, generating a flurry of media hype. Pfizer's office in Argentina has...

Argentina rescinds Spinraza deal

US drugmaker Biogen has had a setback in Argentina. As the country extends its Covid-19 lockdown, the Ministry of Health has removed Obligatory Medical Program (PMO) status from the company's star product Spinraza after only 10 months, opening the path for an arduous process of negotiation. As new generation medicines...

Local buyer for Takeda’s Hepatalgina

English version Argentina's Elea-Phoenix wants to become the main local player in the OTC sector, which has traditionally been dominated by multinationals. It's taken another step towards that goal with the acquisition of the popular cholagogue Hepatalgina. The novel coronavirus is proving no obstacle against deals in other areas of pharma. Pharmabiz has learned...

L’Oréal: new head in Argentina

English version L'Oréal's Argentine operations will be run from the northern hemisphere with a two-hour time difference for the time being as the new local head waits in Mexico for Argentina to reopen its borders. French cosmetics giant L'Oréal has another new head for Argentina after only ten months. The new...

Clorox: new general manager for Argentina

English version The domestic cleaning giant Clorox has a new general manager in Argentina. The man chosen to head up the local branch is Antonio Mosteiro, formerly of Mondelez. He has wide experience in the mass consumer market and arrives as sales of bleach experience a boom on the back...

Stada offloads Vannier, Argentina

English version:  Germany's Stada was sold a pig in a poke back in 2015, but it didn't take long for the company to notice its low chances of success on the local generics market. Now the company is upping sticks and getting out of Argentina. The generics market in Argentina is...

Lilly: new head in Argentina

English version Increasing numbers of executives are taking up positions remotely. One case is the new number one at US drugmaker Eli Lilly's Argentine office, which is now being led by the Brazilian Felipe Borges dos Reis from Brazil. Another executive has taken up his chair in Argentina remotely as the coronavirus...

Biogen under microscope for COVID-19 outbreak

English version US drugmaker Biogen as well as for Spinraza is now famous as the epicentre of multiple coronavirus cases. In Argentina, its regional director has recovered, but the local branch has become a focus point for expansion of the illness along with the company's other offices. It's already known...

Biogen exec COVID-19 green light

English version US-based Biogen has been one of the drugmakers most affected internationally by the coronavirus pandemic. In Argentina, general manger "Maxi" Gutiérrez has announced he is clear of the virus on his Linkedin account. The general manager of Biogen in Argentina, "Maxi" Gutiérrez, has followed the approach of many of his...

US drugmaker in local COVID-19 quarantine

English version The effects of the global coronavirus pandemic have reached Argentina. Most drugmakers are cancelling congresses, conventions and international meetings. The staff of US drugmaker Biogen's Argentina office are working from home in quarantine after several company executives tested positive for COVID-19. US media reports cite three leaders testing positive in...

Sidus seals deal with Lifescan

English version From April 1. Argentine drugmaker Sidus will be the commercial representative of the LifeScan line of blood glucose monitors in Argentina. The brand, which belongs to the private investment firm Platinum Equity has been licensed to firm owned by the Argüelles family and will have no connection with...

Megalabs snaps up GSK brands

English version The Consumer Health sector is seeing continual reorganisation internationally. Joining the list of pharma multinationals who've bought assets only to sell them on not long afterwards is GSK. The drugmaker has offloaded a trio of mature brands in the Latin America region into the hands of the regional...

Takeda sells 18 brands

English version Since Japan's Takeda acquired Shire in 2018, the drugmaker's course towards a specialist focus has been set. The sale of its portfolio of mature drugs has been predicted. Two local brands have changed hands for now as part of a deal with regional reach. Japan's Takeda has sold...

Pfizer CEO in Argentina

English version Argentina's sky-high inflation isn't stopping the multinationals in the sector. Pfizer's gloval CEO was in the country and even donned the jersey of the national football team. He signed balls and had a tête à tête with local staff. Albert Bourla, global CEO of Pfizer was in Argentina...

B. Braun opens €30 million plant

English version Argentina following the rest of the world and has ordered drugmakers to produce parenteral preparations exclusively through closed system technology. To meet the ANMAT's new regulations, Germany's B. Braun is investing €30 million to build a new plant in Mar del Plata to produce for the local market. German drugmaker...

Argentina’s Bagó: 2019 «disappointing»

English version In the event at Hotel Alvear, the group's Juan Carlos Bagó said it would be the last time he presented on stage. He said he was taking a difficult but mature decision to step back from the limelight but would continue firm in the group. The major Argentine...

Biotoscana changes hands

English version The big candidate was Brazil's Eurofarma., but Biotoscana has today officially revealed its new owner is the Canadian company Knight Therapeutics. A mayor player in the region, its future will be followed closely. It's official: Latin American group Biotoscana has changed hands, with the offer from Canada's Knight...

Regulator halts ranitidine production

English version Argentina's regulator ANMAT is taking measures over ranitidine. On the local market, the leading brand is Taural from Roemmers group, but there are many generics distributed through hospitals and retail. The order only affects oral versions. The ranitidine alert is expanding in Latin America, with Argentina's ANMAT stopping production of new lots and other regional regulators issuing their...

Helsinn signs regional deal

English version Switzerland's Helsinn has closed an agreement with Argentina's Varifarma and Brazil's Blanver for the exclusive licensing and representation of one of its pipeline products in the region. The product in question is the potential oncological drug pracinostat, currently at the development stage. Switzerland's Helsinn has signed exclusive distribution and license agreements with Argentina'sVarifarma and Brazil's Blanver through which the companies...

3M shuts plants in Argentina

English version Multinational conglomerate 3M has decided to shut down all three of its Argentine plants including one that manufactures aerosol nebulizers for asthmatics. It will be the first time a pharma plant has shut down in the country outside bankruptcy procedures. US-based 3M has made the decision to shut down its three manufacturing plants in Argentina, one...

Athenex buys CIDAL

English version The USA's Athenex has announced the acquisition of CIDAL, a Guatemala-headquartered firm focusing on clincal trials and studies that operates in several countries in Latin America.  The CRO (contact research organization) segument comprising companies that focus on clinical studies is proving dynamic at the moment with a new acquisition in Latin America. US-based Athenex has announced the purchase...

Ecuador pharmacies growing

English version The pharmacy retail sector in Ecuador saw a pivot after the earthquake of 2016. Many sales points have since opened up outside of traditional downtown city centre areas. The retail pharmacy sector in Ecuador is not only the preserve of Mexico's FEMSA. According to El Diario de Ecuador, pharmacies in the country are expanding operations beyond...

IQVIA in Buenos Aires

English version The 2019 edition of the IQVIA World Review took place today at  a hotel outisde of Buenos Aires, Argentina. Topics included the strengths and weaknesses of social security systems in the region. Former head of health services in Argentina Luis Scervino put the focus on the intangibility of resources belonging to the country's fund...

Sanofi sells Irix and other OTC drugs

English version La francesa Sanofi has begun to strip itself of products that don't form part of its core earners after having taken a packet of OTC brands from Germany's Boehringer Ingelheim. France's Sanofi continues to prune its portfolio. Having broadened its OTC portfolio through a swap with Germany's Boehringer Ingelheim back in 2016, it's peeling off products that...

Schott invests US $13m

English version Germany's Schott, a specialist glass maker that produces glass for the pharmaceutical industry Pharmabiz to tour its manufacturing plant in Rio de Janeiro. The company told Pharmabiz that it would maintain its investments in the region where it operates three production sites, one in Rio where it makes raw materials; one that makes finished products in Sao...

Podcast: the week in English

English Version. The news from the pharma and cosmetic industry from the second week of March. A one-minute overview of the news from the pharmaceutical and cosmetic industry by Joseph Foley. In the podcast this week, the goverment continues its strategy for insulin provision, drugmaker Sanofi lays off five employees and Biogen focuses on the final price...

Novartis: end of cardio in Argentina

English version Swiss drugmaker Novartis is closing the shutters on its cardiometabolic unit in Argentina. As far as Pharmabiz could learn, the mature products Diovan, Galvus and Exforge are being moved off-stage resulting in 35 layoffs. Swiss drugmaker Novartis is closing the shutters on its cardiometabolic unit in Argentina The triad of products in the unit - the valsartan...

Cuts at TRB Pharma

English version Argentina's drugmakers cannot escape the country's recession. Pharmabiz has learned that TRB Pharma has begun crisis prevention measures cutting 10% of its workforce. Argentina's pharma sector is feeling the heat of the country's prolonged recession and economic crisis as local drugmaker TRB Pharma announces a 10% cut to its workforce. The cuts are being made under Argentina's so-called Procedimientos...

Novartis CEO in Argentina

English version The CEO of Novartis is currently in Argentina as part of a Latin American tours that started in Mexico and will wrap up in Sao Paulo, Brazil. There's a star visitor in Argentina this week - the CEO is Swiss drugmaker Novartis, Vasant Narasimhan, who is in the country as part of a...

Podcast: the week in English

English Version. The news from the pharma and cosmetic industry from the second week of February. A one-minute overview of the news from the pharmaceutical and cosmetic industry by Joseph Foley. In the podcast this week, an Argentine group expands its portfolio in Latin America, Swiss drugmaker Novartis announces a new country head, and a local drug...

Roemmers buys Bactrim Latam

English version The Roemmers group has sealed another deal with Swiss drugmaker Roche. It had already bought the company's primary care package in Argentina and now takes on Bactrim and Dormicum for the wider Latam region. Pharmabiz has been told the deal totalled around US$ 75 million. Argentine group Roemmers, which bought out Swiss drugmaker Roche's package of primary care products on the local...

Podcast: the week in English

English Version. The news from the pharmaceutical and cosmetic industry from the first week of February. A one-minute overview of the news from the pharmaceutical and cosmetic industry by Joseph Foley. In the podcast this week, bids on goverment purchases in Argentina while L'Oréal blames its regional downturn in inflation in the country, and Kimberly Clark is to close...

Unilever launches Nexxus in Argentina

English version Unilever continues to bring more personal care brands to the Argentine market, now launching Nexxus, a brand that, although in different channels, will compete with L'oréal's Kérastase. It has eight presentations retailing for an average of AR$500 (US$13) putting it at opposite ends of the market from Unilever's own Sedal, which retails at AR$75. Despite the recession and drop in...

Podcast: the week in English

English Version. The news from the pharmaceutical industry from the last week of January. A one-minute overview of the news from the pharmaceutical industry by Joseph Foley. In the podcast this week, public tenders in Buenos Aires Province, regional restructuring at Roemmers and a new face at Novartis in Argentina. See article in Spanish Ir a descargar

Roemmers group: changes in the region

English version Argentine pharma group Roemmers is making changes and updating its structure throughout the Latin America region. Argentine pharma group Roemmers is updating its structure throughout the Latin America region, the local heavyweight making changes at various units across the continent. Santiago Llavallol has arrived in Peru to replace Pedro Alonso Hidalgo, who crosses to...

Podcast: the week in English

English Version. The news from the pharmaceutical industry from the fourth week of January. A one-minute overview of the news from the pharmaceutical industry by Joseph Foley. In the podcast this week, Venezuelan pharmacy chain Farmatodo touches down in Argentina, fraud at Pierre Fabre, and a send off for a local veteran. See article in Spanish. Ir a descargar

Fraud at Pierre Fabre

English version French drugmaker Pierre Fabre fired its trade marketing manager in Argentina in December and filed a criminal case in Buenos Aires City. A large quantity of missing retail products has been identified and were bought illegally. French drugmaker Pierre Fabre has begun an internal investigation in Argentina to detect the final destination of a substantial quantity...

Podcast: the week in English

The news from the pharmaceutical industry from the third week of January. English Version. A one-minute overview of the news from the pharmaceutical industry by Joseph Foley. This week, businesses and trade unions take stock of the annual inflation figures released by statistics bureau INDEC and drugmakers programme manufacturing cuts over the summer. See article in Spanish Ir a descargar

Inflation in Argentine hygiene, report

English version Prices across all sectors were continually adjusted throughout 2018. Pharmabiz analyzed the movement of the hygiene and personal care basket monitored by Argentina's national statistics institute INDEC. It increased by 65.6% while the general basket of goods measured by the body increased by 47.6%. Argentina's annual inflation for 2018 was the...

Podcast: the week in English

English version. The news from the pharmaceutical industry from the second week of January. A one-minute overview of the news from the pharmaceutical industry by Joseph Foley. This week Takeda's acquisition of Shire, payments from Argentina's pensioners' medical care provider PAMI and price controls on the local market. See article in Spanish Go to download

Podcast: the week in English

English Version. The news from the pharmaceutical industry in the second week of January. A one-minute overview of pharmaceutical news from the first week of 2019 by Joseph Foley. This week, a record-breaking acquisition and inflation in Argentina. See article in Spanish   Ir a descargar  

Podcast: the week in English

A one-minute overview of the news from the pharmaceutical industry in Argentina this Christmas week. This week, the end of the year for local drugmakers plus changes at the former IMS Health and Novartis. Ir a descargar  

Simple launched in Argentina

English version Unilever launches the brand Simple in Argentina aiming at consumers with sensitive skin with a price point  50% above that of Dove. Anglo-Dutch giant Unilever continues to launch brands on the Argentine market despite the challenging economic context. Following the launch of the LivOpen repellants last summer, the group has launched its Simple line of products. The skincare...

Podcast: the week in English

English version Our one-minute overview of pharma news in Argentina for the fourth week of November. This week, Roche leaking execs in the country, while Novartis bids farewell to its country manager José Marcilla as well as American CEO for oncology Aliya Omer. Ir a descargar

Roche Argentina leaking managers

English version The gradual loss of staff at the Argentina subsidiary of Switzerland's Roche has become impossible to hide. Although its communication department continues to try to show the company as a multinational with excellent benefits, the perks are clearly not proving to be enough to retain mid-level executives. Swiss drugmaker Roche is one of the many multinationals that cannot...

Podcast: the week in English

English version Our one-minute audio overview of pharma news in Argentina for the third week of November 2018. This week: Pfizer closes its consumer healthcare business in the Southern Cone.   Ir a descargar

Podcast: the week in English

English version A one-minute audio summary of pharma news in Argentina for the second week of November 2018. The new agreement with the public medical provider PAMI has been made official in an announcement from the Argentine president Mauricio Macri.   Ir a descargar

Novartis oncology, over and out

English version The team at Novartis Oncology in Argentina is waiting expectantly after learning that CEO Aliya Omer is moving on after barely a year in the country. Most of the team is said to have welcomed the news since Omer's particular management meant several had to move departments of even leave the company. We know the multinationals rotate...

Podcast: the week in English

English version A one-minute audio summary of pharma news in Argentina for the first week of November 2018. The public medical provider PAMI and its agreement with drugmakers remains the main story in pharma news. Ir a descargar

Podcast: the week in English

English version A one-minute audio summary of pharma news in Argentina for the last week of October 2018. The main story in this edition: drugmakers' agreements with public medical provider PAMI on a new one-by-one basis.  

L’oréal: Favre to Argentina

English version. Frenchman Damien Favre had to abandon the glamorous Italian market to take on the devalued mass consumption market in Argentina. Favre is starting his tenure with price increases across the division of 14.5%. French giant L'Oréal is bringing in a replacement to head its mass consumption business in Argentina to oversee the firm's strategy in dealing with...

End of an era at Glaxo

English version The tenure of the Argentine Rodolfo Civale at the helm of the UK’s GSK for the Southern Cone has come to an end. His exit will also mean a change at the CAEMe, the association for international drugmakers. It seemed like it would last ever, but the decade-long tenure...

Roemmers buys Sidus Paraguay

English version The Roemmers group continues to expand its presence in the region. It's moved forward two steps in Paraguay with the purchase of the local branch of Sidus as well as the drugmaker Almos to gain scale in the Southern Cone. At the helm of the operation is ex-Rofina man Máximo Barral. Latin America's pharma...

Valsartan measures in Latam

English version The international recall of valsartan is directly impacting the cardio segment in Latin America. After the EMA made the first move and the FDA also stepped in, Pharmabiz analyzes the position of the Latin American regulators. The region's regulators have acted following the EMA's July 5 announcement of the revision of medicines based on valsartan manufactured with defective raw materials. Colombia,...

Layoffs at Glenmark Argentina

English version The Argentine mendicines industry suffers setbacks as Indian drugmaker Glenmark cuts costs and lays off 20% of its manufacturing workforce in the country, Pharmabiz has learned. Indian drugmaker Glenmark is making substantial cuts to its manufacturing staff in Argentina. Pharmabiz has learned from reliable sources that the company, which was held up as a model for local industry during...

Mega Pharma buys Celsius

English version Latin Pharma firms continue to make headlines. Now the Mega Pharma group has bought the Uruguayan drugmaker Celsius in a move that will give it control over 30% of the medicines market in Uruguay. Latin giant Mega Pharma continues to expand reinforcing its operations in the continent. Pharmabiz has learned that the holding company, owned by Thomas Struengmann, has acquired another...

Masipack in crisis in Brazil

English version Brazil's Grupo Masipack, which manufactures machinery for the pharma sector, is in financial crisis. The president of the company blames the problems on the recession in Brazil. Brazil's Grupo Masipack, which manufactures machinery for the pharma sector, is suffering a financial crisis that is affecting delivery times for its products. As far as Pharmabiz could learn, the company is responding...

Sartorius hosts Open Talks

English version Germany's Sartorius is bringing its star speaker Stefan Schlack to Argentina. The executive is arriving in the country for Open Talks at Buenos Aires' MALBA museum. Germany's Sartorius is looking to the region inviting experts and anyone interested in the biotechnology business to attend a talk by its star speaker, the vice president of bioprocesses Stefan Schlack. Schlack, who has been at the corporation...

New investors at Biosidus

English version Argentine drugmaker Biosidus has opened the door to new shareholders: the investment funds Acon Investments and Humus Capital Partners, which will now control the company. Pharmabiz has learned that Biosidus, which had been owned by the García Belmonte family since the divisino of Grupo Sidus in 2010 is being reshaped through the arrival of new shareholders. According to an official release from the...

Argentine pay talks close at 20%

English version Collective pay negotiations in the Argentine pharma sector have closed reaching with an agreement of a 20% pay increase in three phases. The agreement includes update clause based on the consumer price index. After some delay, the collective pay negotiations in the Argentine pharma sector have reached an agreement. Pharmabiz has learned that the sectors'...

Roemmers leaves Mega Pharma

English version The Roemmers family has broken its ties with the Struengmann family, leaving Uruguay-based Latin pharma giant Mega Pharma, which was founded in 2002. International drugmakers are continually restructuring and Latin America's multinationals are no exception. Pharmabiz has learned that the regional giant Mega Pharma, which counted local businessman and pharma reference point Alberto Roemmers as a shareholder, has seen a major...

BMS stikes deal with state producer.

English version The patent on the antirretroviral Reyataz recently expired. The US firm BMS had been selling the product to the Argentine state for a decade as part of the national HIV programme. Generally, the private pharma industry doesn´t look kindly on the state production of medicines. One reason is that while it has sufficient structure to supply the market, public drugmakers require large...

Andrómaco: deal with Leo Pharma

English version Argentine firm Andrómaco has closed a deal with Danish drugmaker Leo Pharma to bring Picato to Argentina The anti-actinic transparent gel will come under the firm's prescription medicines business. Argentine firm Andrómaco has closed a deal with Danish drugmaker Leo Pharma. The company, which belongs to the Roviralta family had already sealed deals with the European counterpart in the past, but is...

Pharma review of the year 2017

English version The "un-termination" of the agreement with PAMI, Argentina’s state funded health provision for pensioners, was possibly the key and most controversial topic of 2017. The agreement was terminated then reactivated in a series of twists that have left many wondering what lays in store for the next agreement due...

Pharmabiz celebrates 10 years

English version Pharmabiz, Latin America's top digital source of news on the pharmaceutical industry, is celebrating ten years. Its first decade of existence has seen it become an indispensable reference for a broad section of the Pharma and cosmetics industries. Online newspapers are defining the era and in this context Pharmabiz, at the forefront of new forms...

Argentina’s reign of fragrance imitations

English version It’s not unusual to come across imitations of luxury fragrances, but companies have taken it as far as Argentine direct sales company Reino. The firm has launched replicas that emulate the details of top fragrances at 80 per cent cheaper. Imitations of luxury fragrances are no novelty. Many low-price lines emulate...

Baxter divests in Argentina

English version: US firm Baxter is divesting in Argentina. Led by regional head Marcelo Rozas, the multinational is in the due diligence process to sell its clinic Daomi for the second time. The change of direction take by Argentine president Mauricio Macri apparently was not enough to convince some multinationals that the country is a reliable market...

Abbott: confusion over new device

English version: Abbott launched a misleading campaign green-lighted by Argentine CEO for the diabetes division, Nicolás Mendiberri, and José María Oribe's press agency, that seemed to falsely suggest the at new blood sugar test completely eliminated the need for finger pricks. US drugmaker Abbott has been accused of launching a misleading ad campaign in Argentina suggesting that...

Pfizer opens new plant

English version US drugmaker Pfizer has opened a new soft capsule production plant in the Buenos Aires neighborhood of Villa Soldati. The company has invested more than US$ 10 million to produce the new dosage form directly in Argentina. US drugmaker Pfizer cut the ribbon today at a new soft capsule plant in...

Exclusive: Argentina’s Sielecki buys back Phoenix from GSK

English version Daniel Sielecki has bought back the drugmaker Phoenix. The company will come under the wings of Elea from December, following seven years of British ownership. The drugmaker Phoenix is flying back to its origins. After just seven years of British ownership, the company has been bought back from GlaxoSmithKline by its original...

Exclusive: Roemmers buys Elisium

English Version Argentina’s Roemmers group has acquired local drugmaker Elisium. Sources have told Pharmabiz that the group will pay close to US$ 20 million to buy the company from Gador and Casasco. Roemmers, the largest pharmaceutical company in Argentina, continues to expand. Pharmabiz has exclusively learned that the group has bought Elisium from...

Sanofi Argentina ousts CEO

English Version French drugmaker Sanofi has said goodbye to its Argentina CEO Sergio Navarro Hufenbach. In a calculated chess move, the Swiss Sebastien Delarive has already stepped into the position. Sometimes company goodbyes come with little notice, but this week's decision at Sanofi Argentina was completely unexpected. As far as Pharmabiz could...

Fresenius opens Argentine plant

English Version German group Fresenius has opened its new manufacturing plant on the Ezeiza industrial park. The site will focus on producing parenteral solutions. German healthcare group Fresenius has launched a new manufacturing plant in Argentina. Located on an industrial park in Ezeiza, in Buenos Aires Province, the new facility involved an investment of almost US $10 million. The group had originally planned a...

Mega Pharma plans stock market launch?

English Version Uruguayan drugmaker Mega Pharma is said to be planning to make an initial public offering either in the US or somewhere in Latin America. Uruguayan drugmaker Mega Pharma is said to be planning to make an initial public offering either in the US or somewhere in Latin America. According to the news...

Puig bets on trips for editors

English Version Drugmarkers’ invitations to science journalists are almost nonexistent these days. Compliance rules, mainly among multinationals, have succeeded in almost burying that practice, but it appears that some cosmetics groups are using the initiative. Drugmarkers’ invitations to science journalists are almost nonexistent these days. Companies used to ferry reporters to international conferences on every specialism going...

IMS: Emerging markets, prices and perspectives

The IMS World Review 2014 took place today in Buenos Aires, at Puerto Salguero, in Costa Salguero exhibition center. English version The IMS World Review 2014 took place today in Buenos Aires, at Puerto Salguero, in Costa Salguero exhibition center. The event covered by Pharmabiz brought together the main members of the...

Novartis: new local head of oncology

English version Gustavo Gil has retired from Swiss drugmaker Novartis. He led the oncology division in Argentina for more than a decade. The American Aliya Omer takes his place. May will be a key month for Novartis’ local oncology business in Argentina, with section head Gustavo Gil stepping down after a decade in the position. The Argentine director, who is retiring, held...

KPMG gets its data in a twist in Argentina

English version International consultation and auditing company KPMG is getting its data in a twist in Argentina, at least in the Pharma sector. International consultation and auditing company KPMG, one of the four giants on the global stage alongside Deloitte, PWC and Ernst & Young is getting its data in a twist in Argentina, at least in the Pharma...

Pharmabiz launches You Tube reports

English Version Pharmabiz, the leading specialist on the Latin American pharmaceutical and cosmetics industries, is expanding its journalistic output to include You Tube video reports. The two-minute micro-reports will be recorded on site at Pharmabiz’s editorial offices, and have the seal and support of the respected media outlet’s journalistic team. See channel. The idea is...

Argentine drugmakers buy bunch of Abbott brands

English Version The deals and acquisitions in the pharma industry continue even as the bells are about to ring for New Year. The deals and acquisitions in the pharma industry continue even as the bells are about to ring for New Year. Argentine drugmakers Microsules, led by the Breitman family, and Biosintex, led...

New player in the Pharma adhesives market

English Version Facundo Schiavone (ex Andreani) and Jorge Muixi (ex H.B. Fuller) have launched a new company in the Argentine market. Facundo Schiavone (ex Andreani) and Jorge Muixi (ex H.B. Fuller) have launched a new company in the Argentine market. With an initial investment of $10 million, the firm will focus on the specialist adhesives sector, catering for different industries,...

Marken (soon to be UPS) cuts the ribbon at new facilities...

English Version Pharmabiz was present as the clinical trials logistics company Marken cut the ribbons on a new operations centre yesterday. Pharmabiz was present as the clinical trials logistics company Marken cut the ribbons on a new operations centre yesterday. The company’s global CEO Wes Wheeler attended the event, along with its...

Dufour returns in the hands of home cleaning products

English Version Argentine men's deodorant and fragrance brand Dufour is returning in the hands of the owners of a classic home cleaning product. Argentine men's deodorant and fragrance brand Dufour is returning in the hands of the owners of a classic home cleaning product. The brand is being relaunched by local firm Villard & Louis, makers...

Argentine pharma companies looking abroad

English Version Argentine firms feeling the pinch from an ongoing recession at home are looking abroad for expansion. Argentine firms feeling the pinch from an ongoing recession at home are looking abroad for expansion. Several local firms are looking to enter new markets and create alliances, mainly in the areas of generics...

Traceability: new rules

English Version As predicted by Pharmabiz, Argentina's regulator ANMAT has introduced new rules for drugs traceability. Ruling number 10564, published in Argentina's governmental bulletin, merges previous lists of active ingredients that must be traced, and adds more. The measure updates lists published in 2011, eliminating close to 100 drugs listed in four rulings emitted...

Richmond continues regional expansion with new company in Uruguay

English Version Argentine drugmaker Richmond, led by Marcelo Figueiras, has informed the country's national securities commission that is has decided to register a limited company in Uruguay. Argentine drugmaker Richmond, led by Marcelo Figueiras, has informed the country's national securities commission that is has decided to register a limited company in Uruguay. The new...

Droguería del Sud opens new facilities

English Version Argentine president Mauricio Macri cut the ribbon at Droguería del Sud's new central distribution centre in the province of Buenos Aires. Argentine president Mauricio Macri cut the ribbon at Droguería del Sud's new central distribution centre in the province of Buenos Aires. Pharmabiz was present at the event, at which Drogería del Sud's president,...

Indian drugmakers focus on Latin America

English Version India’s phamaceutical industry continues to look for strategic allies in Latin America and seems to have its eyes on Peru. India’s phamaceutical industry continues to look for strategic allies in Latin America and seems to have its eyes on Peru. In Argentina, inroads had been made during the previous government’s administration, led by Cristina Fernández...

Colorcon: new CEO and projects

Colorcon has a new regional CEO. Now at the helm in South America is Rafael Falco, who was previously the company’s sales manager for the southern cone. English Version The multinational Colorcon, specialised in colourings and coatings for medicines, has a new regional CEO. Now at the helm in South America is Rafael Falco, who was previously the company’s sales...

Layoffs at AstraZeneca

Anglo-Swedish drugmaker AstraZeneca is laying off 100 employees in Argentina. Under new CEO Gustavo Mizraje, the local operation is making the cuts in the areas of administration and marketing English Version Anglo-Swedish drugmaker AstraZeneca is laying off 100 employees in Argentina, Pharmabiz has learned. Under new CEO Gustavo Mizraje, the local operation is making the cuts in the...

More layoffs at Biogen

English Version Global biotech firm Biogen continues to lay off staff in Argentina while rumours circulate that it might leave the country altogether. Global biotech firm Biogen continues to lay off staff in Argentina while rumours circulate that it might leave the country altogether. The latest news obtained by Pharmabiz is that the multinational...

Bayer event: focus on Latin America

English Version Bayer brought together a legion of Latin American journalists for a press conference in Buenos Aires to outline its plans for the continent and detail its performance in each country. Bayer brought together a legion of Latin American journalists for a press conference in Buenos Aires to outline its plans for...

Danish drugmaker lays off local director

Alberto Weder’s 15-year tenure at the helm of Danish drugmaker Lundbeck’s Argentine concern has been brought to an end. English version Alberto Weder’s 15-year tenure at the helm of Danish drugmaker Lundbeck’s Argentine concern has been brought to an end, Pharmabiz has learned. For the moment, finance director Enrique Alba Valle is acting...

Argentine biotech firm in crisis: debts and layoffs

Sources say the company is considering opening crisis prevention talks with Argentina’s Ministry of Work, but official spokesmen have denied this. English Version Argentine biotech firm Amega Biotech is facing financial difficulties and has begun making layoffs, Pharmabiz has learned. The company officially admitted to Pharmabiz that it has already cut 20 jobs from a total of 300 staff, but reliable...